About Pipette Dreams

Pipette Dreams is an AI-powered biotech research terminal built for analysts, investors, and scientists who need to evaluate drug development programs at scale. The platform connects clinical trial evidence, regulatory timelines, standard-of-care benchmarks, and company financials into a single, explainable scoring framework — so users can understand not just a program's headline score, but the underlying data and assumptions behind it.

For every drug program, Pipette Dreams generates three transparent scores — Clinical Strength, Regulatory Confidence, and Approval Potential — each grounded in the published trial results, FDA designations, and catalyst calendar that drive it, rather than a black-box rating. The terminal tracks late-stage programs through pivotal data readouts, FDA submissions, advisory committees, and PDUFA decisions, so users can follow catalysts as they approach and monitor outcomes as they resolve.

A nightly research pipeline ingests new clinical, regulatory, and market data from public sources, while a weekly calibration loop learns from resolved outcomes and price events to refine future evaluations. The result is a living research terminal that improves as more programs reach their regulatory milestones.

Pipette Dreams is built by a small team focused on making biotech research faster, more transparent, and accessible to independent analysts. It is a research and information platform — not an investment advisor. Nothing on the platform is a recommendation or an offer to buy, sell, or hold any security.